Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Recruiting 5Not yet recruiting 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Genitourinary 5Other hematologic neoplasm 4Tumor-Agnostic 3Gynecologic 3Gastrointestinal 3Other solid neoplasm 1Other neoplasm 1Other 1Lymphoid 1Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

pembrolizumab 66Cisplatin 55Radiotherapy, Intensity-Modulated 28Carboplatin 27Nivolumab 25Paclitaxel 21Magnetic Resonance Spectroscopy 21Radiotherapy 20Cetuximab 16Specimen Handling 15Docetaxel 15Radiation 14Gemcitabine 13Fluorouracil 12Biopsy 12durvalumab 11Platinum 11Taxes 10Drug Therapy 101,2-diaminocyclohexaneplatinum II citrate 10Surveys and Questionnaires 9Capecitabine 9trametinib 8tislelizumab 6lenvatinib 6dabrafenib 6cemiplimab 6atezolizumab 6Radiosurgery 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Interviews as Topic × Head & Neck × Clear all
NCT07556367 2026-06-01

Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients

University of California, San Francisco

Phase NA Active not recruiting
43 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡